Cargando…

Mucosa associated invariant T and natural killer cells in active and budesonide treated collagenous colitis patients

INTRODUCTION: Collagenous colitis (CC) is an inflammatory bowel disease, which usually responds to budesonide treatment. Our aim was to study the immunological background of the disease. METHODS: Analyses of peripheral and mucosal MAIT (mucosa associated invariant T cells) and NK (natural killer) ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daferera, Niki, Nyström, Sofia, Hjortswang, Henrik, Ignatova, Simone, Jenmalm, Maria C., Ström, Magnus, Münch, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798420/ https://www.ncbi.nlm.nih.gov/pubmed/36591297 http://dx.doi.org/10.3389/fimmu.2022.981740

Ejemplares similares

Lack of effect of methotrexate in budesonide-refractory collagenous colitis
por: Münch, Andreas, et al.
Publicado: (2013)

How familiar are we with decision-making concerning the treatment of perforation after endoscopic mucosal resection (EMR) in the colon? A case report
por: Tribonias, George, et al.
Publicado: (2018)

Microscopic colitis: Struggling with an invisible, disabling disease
por: Pihl Lesnovska, Katarina, et al.
Publicado: (2019)

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial
por: Münch, Andreas, et al.
Publicado: (2016)

Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis
por: Vafaei, Seyed Yaser, et al.
Publicado: (2022)

Use of Budesonide in the Treatment of Microscopic Colitis
por: Tangri, Vikram, et al.
Publicado: (2010)

Nintedanib-Induced Colitis Treated Effectively With Budesonide
por: Amini, Afshin, et al.
Publicado: (2020)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis
por: Lichtenstein, Gary R.
Publicado: (2015)

Budesonide-Related Iatrogenic Cushing’s Syndrome in Microscopic Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2017)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial
por: Münch, Andreas, et al.
Publicado: (2021)

Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation
por: Fang, Qiuhong, et al.
Publicado: (2013)

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
por: Iborra, Marisa, et al.
Publicado: (2014)

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
por: Hughes, Michael S., et al.
Publicado: (2019)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, γδ T cells, and mucosa-associated invariant T cells
por: Singh, Parvind, et al.
Publicado: (2022)

Cancer Risk in Collagenous Colitis
por: Larsson, Johanna K., et al.
Publicado: (2019)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis
por: Zhou, Hong, et al.
Publicado: (2018)

Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
por: Shibuya, Tomoyoshi, et al.
Publicado: (2019)

Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
por: Xian, Shiyun, et al.
Publicado: (2023)

Modulatory Function of Invariant Natural Killer T Cells in Systemic Lupus Erythematosus
por: Chuang, Yi-Ping, et al.
Publicado: (2012)

Peripheral Blood Invariant Natural Killer T Cells of Pig-Tailed Macaques
por: Li, Xiangming, et al.
Publicado: (2012)

Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells
por: Doherty, Derek G., et al.
Publicado: (2018)

Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
por: Trottein, François, et al.
Publicado: (2018)

Impact of Aging on the Phenotype of Invariant Natural Killer T Cells in Mouse Thymus
por: Papadogianni, Georgia, et al.
Publicado: (2020)

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
por: Pecher, Ann-Christin, et al.
Publicado: (2019)

Mitochondrial metabolism is essential for invariant natural killer T cell development and function
por: Weng, Xiufang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4fdtihiut26blbngcn8u68pv52